{
  "event_id": "cdd668a4e1c7",
  "ticker": "AMRX",
  "company_name": "Amneal Pharmaceuticals",
  "drug_name": "BONCRESA",
  "pdufa_date": "20251219",
  "approval_type": {
    "status": "found",
    "value": "bla",
    "source": "websearch:Phase 3 biosimilar comparability",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.118552",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Osteoporosis (denosumab biosimilar)",
    "source": "websearch:Phase 3 biosimilar comparability",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.118554",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "denosumab-mobz",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Metabolic",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.466073",
    "error": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:Phase 3 biosimilar comparability",
    "confidence": 0.85,
    "evidence": [
      "Phase 3 biosimilar comparability"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.118539",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "biosimilar",
    "source": "websearch",
    "confidence": 0.85,
    "trial": null,
    "tier": 2,
    "note": "No numeric p-value applicable"
  },
  "p_value_numeric": null,
  "effect_size": {
    "status": "found",
    "value": "BMD change within equivalence margins vs Prolia",
    "source": "websearch:Phase 3 biosimilar comparability",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.118549",
    "error": null
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "default_for_approved",
    "confidence": 0.9,
    "tier": 1,
    "note": "No blocking safety signals at approval"
  },
  "phase3_study_names": [
    "A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis"
  ],
  "nct_ids": [
    "NCT03989349"
  ],
  "enrollment": {
    "count": 787,
    "type": "ACTUAL",
    "nct_id": "NCT03989349",
    "source": "clinicaltrials.gov",
    "fetched_at": "2026-01-10T17:24:52.480382"
  },
  "has_prior_crl": {
    "status": "found",
    "value": true,
    "source": "derived_from_resubmission",
    "confidence": 0.85,
    "tier": 2
  },
  "prior_crl_reason": null,
  "is_resubmission": {
    "status": "found",
    "value": true,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "result": "approved",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:40:01.999920",
  "enriched_at": "2026-01-12T08:48:42.958962",
  "needs_manual_review": false,
  "review_reasons": [],
  "original_case_id": "e1e5a8d9dc31",
  "fda_designations": {
    "breakthrough_therapy": false,
    "fast_track": false,
    "priority_review": false,
    "orphan_drug": false,
    "accelerated_approval": false
  },
  "mechanism_of_action": "Insulin (biosimilar)",
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "outcome": null,
    "vote": null
  },
  "days_to_pdufa": -22,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:37.348688",
  "breakthrough_therapy": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:48:22.398942",
    "search_status": "CONFIRMED_NONE"
  },
  "orphan_drug": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:48:27.450559",
    "search_status": "CONFIRMED_NONE"
  },
  "priority_review": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:48:32.365235",
    "search_status": "CONFIRMED_NONE"
  },
  "fast_track": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:48:37.564067",
    "search_status": "CONFIRMED_NONE"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:48:42.958218",
    "search_status": "CONFIRMED_NONE"
  }
}